Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2014
06/11/2014CN102373181B Swine influenza virus-porcine reproductive and respiratory syndrome virus mixed virus-like particle, and preparation method and use thereof
06/11/2014CN102370976B Mixed virus-like particles of swine influenza virus and foot and mouth disease virus, preparation method and application thereof
06/11/2014CN102293766B Application of active natural product B used for preparing antifungal product
06/11/2014CN102286085B Peganum harmala lipid transfer protein and preparation method and use thereof
06/11/2014CN102274250B External patch Chinese medicine for treating phthisis and preparation method thereof
06/11/2014CN102215852B Agent having anti-helicobacter pylori activity
06/11/2014CN102140100B Polycyclic compound for inhibiting hepatitis C virus efficiently, preparation method thereof and application thereof
06/11/2014CN102133336B Traditional Chinese medicine composite, and preparation method and application thereof
06/11/2014CN101899471B Recombinant retrovirus vector for simultaneously expressing antigen-specific receptor and exogenous gene, B-lymphocyte modified by using same and application thereof
06/10/2014US8748566 Pharmacologically active antiviral peptides and methods of use
06/10/2014US8748565 Pharmacologically active antiviral peptides and methods of their use
06/10/2014US8748486 Inhibitors of yeast filamentous growth and method of their manufacture
06/10/2014US8748373 Hepatitis B virus compositions and methods of use
06/10/2014US8748372 Polynucleotide encoding a TRIM-cyp polypeptide, compositions thereof, and methods of using same
06/10/2014US8747896 Mucosal bioadhesive slow release carrier for delivering active principles
06/10/2014US8747883 Medical item for long term drug release
06/10/2014US8747864 Staphylococcus aureus proteins and nucleic acids
06/10/2014US8747859 Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142
06/10/2014US8747109 Dental appliances and methods for their fabrication
06/10/2014CA2777664C Macrocyclic integrase inhibitors
06/10/2014CA2777024C Sprayable gel wound dressing
06/10/2014CA2711863C Antibody directed against pcrv
06/10/2014CA2673183C Bicyclic pyrimidinones and uses thereof
06/10/2014CA2667091C Method for correcting a lipid imbalance in a subject
06/10/2014CA2635205C Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives
06/10/2014CA2634056C Amorphous form of 1,2-dihydropyridine compound
06/10/2014CA2606386C Therapeutic compositions
06/10/2014CA2554683C Use of alkaline phosphatase for the detoxification of lps present at mucosal barriers
06/10/2014CA2481318C Identification of virulence associated regions rd1 and rd5 leading to improve vaccine of m. bovis bcg and m. microti
06/10/2014CA2441287C Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins
06/10/2014CA2326598C Fusion proteins of mycobacterium tuberculosis antigens and their uses
06/10/2014CA2287451C Topical use of probiotic bacillus spores to prevent or control microbial infections
06/05/2014WO2014085795A1 Mixed lineage kinase inhibitors for hiv/aids therapies
06/05/2014WO2014085580A1 Methods and compositions involving a flu vaccine
06/05/2014WO2014085576A1 Synergistic combinations of fungicides and physical membrane disrupting agents and methods of use
06/05/2014WO2014085419A1 Engineering the production of a conformational variant of occidiofungin that has enhanced inhibitory activity against fungal species
06/05/2014WO2014083060A2 Pseudomonas antigens and antigen combinations
06/05/2014WO2014082935A1 Cyclic nucleoside derivatives and uses thereof
06/05/2014WO2014082592A1 Neuraminidase inhibitor prodrug and composition and use thereof
06/05/2014WO2014082514A1 Method for initiating stem cells of mammals and use of chlorine dioxide in preparation of drug for initiating stem cells of mammals
06/05/2014WO2014082381A1 Spiro ring compounds as hepatitis c virus inhibitors, pharmaceutical compositions and uses thereof
06/05/2014WO2014082379A1 Spiro ring compound as hepatitis c virus (hcv) inhibitor and uses thereof field of the invention
06/05/2014WO2013106689A8 Hcv ns3 protease inhibitors
06/05/2014US20140154772 Inhibitors of human phosphatidylinositol 3-kinase delta
06/05/2014US20140154267 Use of interleukin-4 antagonists and compositions thereof
06/05/2014US20140154216 Virus strains
06/05/2014US20140154215 Herpes virus strains
06/05/2014DE112012002813T5 Kombinationsbehandlung (zB mit ABT-072 oder ABT-333 von DAAs zur Verwendung in der Behandlung von HCV) Combination treatment (eg with ABT-072 or ABT-333 of DAAs for use in the treatment of HCV)
06/05/2014DE102012022778A1 Medicine useful for treating cancer, heart attack and tuberculosis, comprises active ingredient e.g. theobromine which is alkaloid obtained from cocoa, lichenin which is antibiotic derived from oats and caffeine obtained from coffee
06/04/2014EP2738163A1 Amidine compound or salt thereof
06/04/2014EP2738156A1 9-aminomethyl substituted tetracycline compound
06/04/2014EP2737903A1 Antimicrobial activity enhancing agent
06/04/2014EP2737900A1 Ndm inhibitor
06/04/2014EP2736903A1 Aryl naphthalide lignans as anti-hiv agents
06/04/2014EP2736893A1 Thiophene compounds
06/04/2014EP2736887A1 Hydrazide containing nuclear transport modulators and uses thereof
06/04/2014EP2736537A2 Synthetic nanocarriers that generate humoral and cytotoxic t lymphocyte (ctl) immune responses
06/04/2014EP2736532A2 Compositions and methods for improving potency and breadth or hiv antibodies
06/04/2014EP2736519A1 Alkaline compositions and their dental and medical use
06/04/2014EP2736508A1 Pharmaceutical compositions comprising sulbactam and beta-lactamase inhibitor
06/04/2014EP2736500A1 Use of tmprss2 inhibitors as medicaments
06/04/2014CN1585772B Chemokine receptor antagonists and methods of use thereof
06/04/2014CN103842372A Cyclosporin derivatives
06/04/2014CN103842369A Compounds and pharmaceutical compositions for the treatment of viral infections
06/04/2014CN103842364A Anti-viral compounds
06/04/2014CN103842360A N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate having a specific particle size distribution range and a specific surface area range for use in pharmaceutical formulations
06/04/2014CN103842359A N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate
06/04/2014CN103841993A Human enterovirus specific antibodies and their uses in diagnostics
06/04/2014CN103841982A Prevention and treatment of HIV infection
06/04/2014CN103841969A Treatment and prevention of diseases mediated by microorganisms via drug-mediated manipulation of the eicosanoid balance
06/04/2014CN103841962A Darunavir formulations
06/04/2014CN103834669A Oral vaccine of streptococcus agalactiae and preparation method thereof
06/04/2014CN103834620A Newcastle disease virus, newcastle disease inactivated vaccine and preparation method of newcastle disease inactivated vaccine
06/04/2014CN103834619A Duck virus hepatitis virus, duck virus hepatitis inactivated vaccine and preparation method of duck virus hepatitis inactivated vaccine
06/04/2014CN103834617A Human enterovirus 71-type C4-subtype lethal strain SD095 and its application
06/04/2014CN103834614A Preparation method for monkshood polysaccharide-induced nature killer T (NKT) cell proliferation and application thereof
06/04/2014CN103833865A Method for preparing streptococcus pneumoniae capsular polysaccharide
06/04/2014CN103833857A Recombinant fusion protein hIFN gamma-MAP30 as well as preparation method and application of recombinant fusion protein hIFN gamma-MAP30
06/04/2014CN103833848A Egg yolk antibody for preventing and curing muscovy duck parvovirus diseases
06/04/2014CN103833830A Conservative neutralizing epitope polypeptide of Coxsackievirus A16 and application thereof
06/04/2014CN103833812A Pyrazine derivative and medical application thereof
06/04/2014CN103833799A Glucose iodine derivative, preparation method thereof and application thereof in pharmacy
06/04/2014CN103833772A Method for synthesizing cephalosporin
06/04/2014CN103833750A Salt of dehydroapocavidine derivative
06/04/2014CN103833749A Salt of apocavidine derivative
06/04/2014CN103833748A Salt of thalicarpine urbaini derivative
06/04/2014CN103833747A Salt of coptisine derivative
06/04/2014CN103833746A Salt of stylopine derivative
06/04/2014CN103830747A Genetically engineered vaccine of epsilon toxin of clostridium perfringens and application thereof
06/04/2014CN103830746A Riemerella anatipestifer deoxyribonucleic acid (DNA) vaccine based on OmpA (octamethyl pyrophosphoramide) gene and preparation method of vaccine
06/04/2014CN103830726A Antimicrobial organic nanometer composition and preparation method thereof
06/04/2014CN103830724A Muscovy duck parvovirus inactivation vaccine and application thereof
06/04/2014CN103830723A Preparation method of streptococcus pneumoniae capsular polysaccharide protein conjugate vaccine
06/04/2014CN103830722A Clostridium perfringens beta toxin genetic engineering vaccine and application thereof
06/04/2014CN103830708A Formula of special-effect traditional Chinese medicine for treating AIDS (acquired immune deficiency syndrome) and preparation method thereof
06/04/2014CN103830704A Acupoint paste for treating adult cold
06/04/2014CN103830700A Traditional Chinese medicinal composition for treating measles and preparation method thereof
06/04/2014CN103830667A Chinese medicinal composition for treating viral hepatitis
06/04/2014CN103830652A Traditional Chinese medicine for lavipeditum for treating damp heat constitution and preparation method thereof
06/04/2014CN103830651A Oral cavity fungistat and preparation method thereof
1 ... 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 ... 1798